Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
146.97
-2.73 (-1.82%)
Official Closing Price
Updated: 7:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
94
95
Next >
Pension Plan Redux: 3 Companies That Could Take a Page From IBM’s Playbook
February 24, 2024
A new wrinkle from IBM regarding its pension plans could save the company hundreds of millions in future defined contribution payments.
Via
InvestorPlace
Evaluating Johnson & Johnson Against Peers In Pharmaceuticals Industry
February 23, 2024
Via
Benzinga
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price.
Via
InvestorPlace
FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients
February 21, 2024
FDA greenlights Johnson & Johnson's Tecvayli for reduced dosing in multiple myeloma patients, achieving complete response for 6+ months.
Via
Benzinga
Exposures
Product Safety
2 Beaten-Down Stocks to Buy and Hold for 10 Years
February 21, 2024
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles.
Via
The Motley Fool
Is NYSE:JNJ suited for dividend investing?
February 21, 2024
Balancing Dividends and Fundamentals: The Case of JOHNSON & JOHNSON (NYSE:JNJ).
Via
Chartmill
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
February 20, 2024
Via
Benzinga
What the Options Market Tells Us About Johnson & Johnson
February 16, 2024
Via
Benzinga
Looking Into Johnson & Johnson's Recent Short Interest
February 07, 2024
Via
Benzinga
Top 7 Contenders to Join the Trillion-Dollar Club
February 20, 2024
Microsoft's ascent to the $3 trillion mark highlights the growing influence of trillion-dollar companies in the stock market.
Via
InvestorPlace
5 Forever Dividend Stocks to Build Your Portfolio
February 20, 2024
These five stocks are high quality and reliable.
Via
The Motley Fool
Income Lover’s Paradise: 3 Dividend Stocks with Stellar Track Records
February 20, 2024
Over 60 years of annual dividend growth signals that these dividend stocks are quality companies with durable competitive advantages.
Via
InvestorPlace
The Smartest Dividend Stocks to Buy With $400 Right Now
February 19, 2024
These companies will build an ever-growing stream of passive income, one share at a time.
Via
The Motley Fool
Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul
February 18, 2024
AAPL, AB InBev, and Johnson & Johnson are some of the best blue-chip stocks to buy and hold to fortify your investment portfolio.
Via
InvestorPlace
Is Johnson & Johnson Stock a Buy Now?
February 07, 2024
Don't overlook this boring company's stellar reliability.
Via
The Motley Fool
If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today
February 18, 2024
Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good investment?
Via
The Motley Fool
3 Unstoppable Dividend Stocks That Could Pay You for Life
February 17, 2024
There are no certainties in life or on the stock market. These companies' dividends are about as close as we can get.
Via
The Motley Fool
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.
Via
InvestorPlace
7 Small-Cap Stocks With Significant Upside Potential in 2024
February 15, 2024
Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on.
Via
InvestorPlace
7 Stable Dividend Stocks to Ease Lingering Market Jitters
February 13, 2024
Although the economic coast seems clear, those who are still unsure can trust in the reliability of stable dividend stocks to buy.
Via
InvestorPlace
3 Dow Stocks You Can Confidently Buy Now and Hold Forever
February 13, 2024
Three highly profitable, time-tested Dow components have the necessary tools to make their patient shareholders notably richer.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 12, 2024
These incredible businesses have long histories of successes behind them, and more to come.
Via
The Motley Fool
Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now
February 12, 2024
If you are looking to build wealth through dividend income, here are the passive income blue-chip stocks to buy.
Via
InvestorPlace
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
February 09, 2024
Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024.
Via
Benzinga
Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income
February 09, 2024
Unlock reliable cash flow with these Dividend Aristocrats. They're elite S&P 500 dividend stocks raising payouts for 25+ years.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
Via
Benzinga
3 Dividend Stocks to Cling to This Year
February 09, 2024
Build a retirement portfolio with these three dividend stocks to enjoy passive income and capital growth over the years.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
The Watch List: Is Warren Buffett Still Selling These 3 Stocks?
February 08, 2024
Just because Warren Buffett marked these as stocks to sell doesn't always mean investors need to walk lockstep with him.
Via
InvestorPlace
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
February 08, 2024
The healthcare conglomerate has been raising its dividend payout since Kennedy was president, but there have been some recent changes.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
94
95
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.